Incentives for Using Biosimilars in France and Europe

This report examines the growth and impact of biosimilars in France and Europe, highlighting their economic benefits and the incentives introduced to enhance their adoption. It discusses the significant savings generated by biosimilars, the role of hospitals, and the varying incentive measures across different countries. The analysis provides insights into the future of biosimilars in the context of healthcare costs and patient access, emphasizing the need for continued support and adaptation of